Jiangsu Yangtze River Pharmaceutical Group Company Ltd.
Jiangsu Yangtze River Pharmaceutical Group Company Ltd., commonly referred to as Yangtze River Pharmaceutical, is a prominent player in the pharmaceutical industry, headquartered in Jiangsu, China. Established in 1994, the company has grown to become a leading manufacturer and supplier of a diverse range of pharmaceutical products, including active pharmaceutical ingredients (APIs) and finished dosage forms. With a strong focus on research and development, Yangtze River Pharmaceutical has achieved significant milestones, including numerous certifications and partnerships that enhance its market position. The company is renowned for its commitment to quality and innovation, offering unique products that cater to various therapeutic areas. As a key contributor to the global pharmaceutical landscape, Yangtze River Pharmaceutical continues to expand its operational reach, solidifying its reputation as a trusted name in healthcare solutions.
DitchCarbon Score
How does Jiangsu Yangtze River Pharmaceutical Group Company Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Jiangsu Yangtze River Pharmaceutical Group Company Ltd.'s score of 20 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Jiangsu Yangtze River Pharmaceutical Group Company Ltd.'s reported carbon emissions
Jiangsu Yangtze River Pharmaceutical Group Company Ltd., headquartered in CN, currently does not have available carbon emissions data or specific reduction targets. Without reported emissions figures, it is challenging to assess their carbon footprint or the scope of their emissions (Scope 1, 2, or 3). Additionally, there are no documented climate commitments or initiatives aimed at reducing greenhouse gas emissions. As the pharmaceutical industry increasingly focuses on sustainability, Jiangsu Yangtze River Pharmaceutical Group may need to establish clear climate strategies and targets to align with global efforts in combating climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Jiangsu Yangtze River Pharmaceutical Group Company Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
